A novel recombinant anti-cluster of differentiation 20 humanized monoclonal antibody (B001) for the treatment of neuromyelitis optica spectrum disorder: a phase 1, multicenter randomized, double-blind trial.
来源：PubMed发布日期：2026-01-01作者：Jia D, Wang H, Jiang W, Shen Y, Guo J1 次点击